Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
98.13
+3.34 (3.52%)
At close: Aug 4, 2026, 4:00 PM EDT
99.00
+0.87 (0.89%)
Pre-market: Aug 5, 2026, 8:51 AM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $5.92 billion as of August 5, 2026. Its market cap has increased by 1,062.32% in one year.
Market Cap
5.92B
Enterprise Value
5.42B
1-Year Change
1,062.32%
Ranking
Category
Stock Price
$98.13
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $5.92B, an increase of 596.84%. That is a compound annual growth rate of 173.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.92B | 303.36% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.46B |
| Erasca | 6.30B |
| CG Oncology | 6.28B |
| Belite Bio | 6.24B |
| Xenon Pharmaceuticals | 6.06B |
| Dianthus Therapeutics | 5.84B |
| Definium Therapeutics | 5.78B |
| Ligand Pharmaceuticals | 5.70B |